四环生物
(000518)
| 流通市值：21.52亿 | | | 总市值：21.52亿 |
| 流通股本：10.30亿 | | | 总股本：10.30亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 20,710,678.29 | 21,874,537.69 | 25,637,530.7 | 28,180,123.46 |
| 结算备付金 | 0 | - | - | 0 |
| 拆出资金 | 0 | - | - | 0 |
| 衍生金融资产 | 0 | - | - | 0 |
| 应收票据及应收账款 | 78,387,326.41 | 78,935,300.62 | 77,066,984.91 | 100,116,017.59 |
| 其中：应收票据 | 0 | - | - | 0 |
| 应收账款 | 78,387,326.41 | 78,935,300.62 | 77,066,984.91 | 100,116,017.59 |
| 应收款项融资 | 5,257,784.03 | 11,978,079.4 | 9,629,164.96 | 4,354,248 |
| 预付款项 | 7,968,210.63 | 5,276,551.41 | 4,532,608.31 | 4,789,593.61 |
| 应收保费 | 0 | - | - | 0 |
| 应收分保账款 | 0 | - | - | 0 |
| 应收分保合同准备金 | 0 | - | - | 0 |
| 其他应收款合计 | 8,965,682.1 | 7,558,637.01 | 9,962,847.27 | 9,372,565.11 |
| 其中:应收利息 | 0 | - | - | 0 |
| 应收股利 | 0 | - | - | 0 |
| 买入返售金融资产 | 0 | - | - | 0 |
| 存货 | 416,023,046.03 | 415,898,790.69 | 410,622,090.87 | 408,764,642.59 |
| 合同资产 | 3,746,090.6 | 3,866,090.6 | 3,459,419.3 | 5,636,090.6 |
| 一年内到期的非流动资产 | 0 | - | - | 0 |
| 其他流动资产 | 3,513,084.31 | 3,402,853.45 | 3,505,357.57 | 3,445,460.67 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 544,708,119.5 | 548,936,578.52 | 544,569,065.04 | 564,819,858.63 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | 0 | - | - | 0 |
| 债权投资 | 0 | - | - | 0 |
| 其他债权投资 | 0 | - | - | 0 |
| 长期应收款 | 0 | - | - | 0 |
| 长期股权投资 | 549,641.95 | 578,709.04 | 321,871.69 | 539,896.59 |
| 其他权益工具投资 | 0 | - | - | 0 |
| 其他非流动金融资产 | 0 | - | - | 0 |
| 投资性房地产 | 33,387,075.34 | 34,191,208.69 | 35,553,265.57 | 35,799,475.39 |
| 固定资产 | 48,416,846.35 | 50,028,119.73 | 48,834,618.49 | 51,512,722.92 |
| 在建工程 | 593,000 | 483,000 | 2,327,010 | 2,128,210 |
| 生产性生物资产 | 0 | - | - | 0 |
| 油气资产 | 0 | - | - | 0 |
| 使用权资产 | 27,876,367.92 | 29,058,039.54 | 30,239,711.16 | 31,421,382.78 |
| 无形资产 | 26,295,616.22 | 27,881,218.33 | 29,473,491.28 | 31,065,764.23 |
| 开发支出 | 10,980,000 | 15,580,000 | 15,580,000 | 15,580,000 |
| 商誉 | 0 | - | - | 0 |
| 长期待摊费用 | 0 | - | - | 0 |
| 递延所得税资产 | 5,867,751.12 | 5,818,287.88 | 5,978,289.39 | 5,211,152.01 |
| 其他非流动资产 | 0 | - | - | 0 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 153,966,298.9 | 163,618,583.21 | 168,308,257.58 | 173,258,603.92 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 698,674,418.4 | 712,555,161.73 | 712,877,322.62 | 738,078,462.55 |
| 流动负债: | | | | |
| 短期借款 | 16,000,000 | 16,000,000 | 16,000,000 | 16,000,000 |
| 向中央银行借款 | 0 | - | - | 0 |
| 吸收存款及同业存放 | 0 | - | - | 0 |
| 拆入资金 | 0 | - | - | 0 |
| 交易性金融负债 | 0 | - | - | 0 |
| 衍生金融负债 | 0 | - | - | 0 |
| 应付票据及应付账款 | 59,541,498.69 | 65,639,765.28 | 55,487,265.94 | 52,697,996.28 |
| 其中：应付票据 | 0 | - | - | 0 |
| 应付账款 | 59,541,498.69 | 65,639,765.28 | 55,487,265.94 | 52,697,996.28 |
| 预收款项 | 5,687,083.33 | 6,081,145.83 | 6,869,270.83 | 6,869,270.83 |
| 合同负债 | 12,477,600.97 | 12,706,485.85 | 11,291,544.48 | 11,750,608.6 |
| 卖出回购金融资产款 | 0 | - | - | 0 |
| 应付手续费及佣金 | 0 | - | - | 0 |
| 应付职工薪酬 | 192,676.32 | 741,761.83 | 530,623.95 | 5,617,224.8 |
| 应交税费 | 6,278,670.89 | 5,991,771.95 | 6,487,634.08 | 8,833,599.51 |
| 其他应付款合计 | 14,611,109.32 | 15,973,911.48 | 8,030,905.56 | 7,289,748.48 |
| 其中:应付利息 | 0 | - | - | 0 |
| 应付股利 | 668,239.82 | 668,239.82 | 668,239.82 | 668,239.82 |
| 应付分保账款 | 0 | - | - | 0 |
| 保险合同准备金 | 0 | - | - | 0 |
| 代理买卖证券款 | 0 | - | - | 0 |
| 代理承销证券款 | 0 | - | - | 0 |
| 一年内到期的非流动负债 | 4,610,884.83 | 4,522,957.15 | 4,383,992.39 | 4,383,992.39 |
| 其他流动负债 | 3,155,076.72 | 3,030,232.18 | 2,980,530.16 | 2,774,817.29 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 122,554,601.07 | 130,688,031.55 | 112,061,767.39 | 116,217,258.18 |
| 非流动负债: | | | | |
| 长期借款 | 0 | - | - | 0 |
| 应付债券 | 0 | - | - | 0 |
| 优先股 | 0 | - | - | 0 |
| 永续债 | 0 | - | - | 0 |
| 租赁负债 | 28,494,313.15 | 28,304,796.07 | 28,442,409.45 | 28,365,850.64 |
| 长期应付款 | 0 | - | - | 0 |
| 长期应付职工薪酬 | 0 | - | - | 0 |
| 预计负债 | 187,081.26 | 187,081.26 | - | 0 |
| 递延收益 | 0 | - | - | 0 |
| 递延所得税负债 | 0 | - | - | 0 |
| 其他非流动负债 | 0 | - | - | 0 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 28,681,394.41 | 28,491,877.33 | 28,442,409.45 | 28,365,850.64 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 151,235,995.48 | 159,179,908.88 | 140,504,176.84 | 144,583,108.82 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,029,556,222 | 1,029,556,222 | 1,029,556,222 | 1,029,556,222 |
| 其他权益工具 | 0 | - | - | 0 |
| 优先股 | 0 | - | - | 0 |
| 永续债 | 0 | - | - | 0 |
| 资本公积 | 35,572,769.72 | 35,572,769.72 | 35,572,769.72 | 35,572,769.72 |
| 减:库存股 | 0 | - | - | 0 |
| 其他综合收益 | 877,212.14 | 877,212.14 | 877,212.14 | 877,212.14 |
| 专项储备 | 0 | - | - | 0 |
| 盈余公积 | 37,856,747.22 | 37,856,747.22 | 37,856,747.22 | 37,856,747.22 |
| 一般风险准备 | 0 | - | - | 0 |
| 未分配利润 | -589,939,578.18 | -584,397,497.52 | -565,581,208.49 | -546,622,100.04 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 513,923,372.9 | 519,465,453.56 | 538,281,742.59 | 557,240,851.04 |
| 少数股东权益 | 33,515,050.02 | 33,909,799.29 | 34,091,403.19 | 36,254,502.69 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 547,438,422.92 | 553,375,252.85 | 572,373,145.78 | 593,495,353.73 |
| 负债和股东权益合计 | 698,674,418.4 | 712,555,161.73 | 712,877,322.62 | 738,078,462.55 |
| 公告日期 | 2023-10-27 | 2023-08-23 | 2023-04-29 | 2023-04-27 |
| 审计意见(境内) | | | | 带强调事项段的无保留意见 |